Skip to main content

Table 6 Univariate analyses of risk factors for HBdec

From: Role of the initial degree of anaemia and treatment model in the prognosis of gastric cancer patients treated by chemotherapy: a retrospective analysis

 

p value

HR

95%CI

Metastases

 metastatic sites ≥3

0.141

0.838

0.663–1.060

 metastatic sites < 3

   

Metastatic site

 Lymph node

0.325

1.131

0.885–1.444

 Liver

0.328

1.107

0.903–1.358

 Lung

0.936

0.989

0.763–1.283

 Bone

0.017

0.574

0.365–0.905

Chemotherapy regimen

 Included paclitaxel

0.876

0.984

0.802–1.207

 Included platinum

0.010

0.645

0.463–0.899

Number of cycles

< 0.001

0.933

0.907–0.961

Number of PTX3*

0.161

0.96

0.908–1.016

Treatment response

 Progressive disease

0.037

0.798

0.646–0.986

 Non-progressive disease

   
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us